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Background
Natural killer (NK) cells are highly effective in control-
ling tumour growth, in mice, but have no significant
effect in humans. The reason(s) of this phenomenon is
(are) unclear.
Methods
The effects of cancer cells on NK cells during target-
effector cell conjugation was investigated utilising stan-
dard immunological methods including flow cytometry,
chromium release and enzyme-linked immunosorbent
assays while gene expression was evaluated by quantita-
tive reverse transcriptase-polymerase chain reaction.
Results
We found that this phenomenon was associated with the
different susceptibility of human and mouse NK cells to
autologous tumour cell-induced NK cell abnormalities
(NKCA). The latter includes CD16 down-regulation and
NK cell depletion. Induction of NKCA by leukaemia and
solid tumour cells was influenced neither by IL2 treatment
nor by HLA class I antigen expression, but was abrogated
by a 10 day culture. Following a 10 day of PBMCs culture,
NK cells became resistant to leukaemia and solid tumor
cell induced NKCA but maintained their cytotoxic activity.
Actinomycin D restored the susceptibility of long term NK
(LTNK) cells to NKCA suggesting that the generation of
resistance to NKCA required RNA transcription. TAPI-0,
a functional analogue of the tissue inhibitor of metallopro-
teinases (TIMP) 3 inhibited cancer cell induced NKCA
underlying a role for a restricted number of metalloprotei-
nases in the generation of this phenomenon. Finally, we
found an association of TIMP3 gene and protein over-
expression with the reduced susceptibility of LTNK cells
to cancer cell induced NKCA.
Conclusions
This study provides evidence that TIMP3 plays a role in
the protection of LTNK cells from cancer cell induced
NKCA.
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